NCT05325177View on ClinicalTrials.gov

PDA Treatment With Ibuprofen and Changes in Tissue Oxygenation.

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 1, 2024

Study Completion Date

December 31, 2024

Conditions
Patent Ductus Arteriosus After Premature Birth
Interventions
DRUG

Standard Dose Ibuprofen

(10-5-5 mg/kg) 1 dose every 24 hours after enrollment, for a total of 3 doses

DRUG

High Dose Ibuprofen

(20-10-10 mg/kg) 1 dose every 24 hours after enrollment, for a total of 3 doses

Trial Locations (1)

Unknown

RECRUITING

The Ottawa General Hospital, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER